Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).
Ferreras C, Hernández-Blanco C, Martín-Quirós A, Al-Akioui-Sanz K, Mora-Rillo M, Ibáñez F, Díaz-Almirón M, Cano-Ochando J, Lozano-Ojalvo D, Jiménez-González M, Goterris R, Sánchez-Zapardiel E, de Paz R, Guerra-García P, Queiruga-Parada J, Molina P, Briones ML, Ruz-Caracuel B, Borobia AM, Carcas AJ, Planelles D, Vicario JL, Moreno MÁ, Balas A, Llano M, Llorente A, Del Balzo Á, Cañada C, García MÁ, Calvin ME, Arenas I, Pérez de Diego R, Eguizábal C, Soria B, Solano C, Pérez-Martínez A. Ferreras C, et al. Among authors: guerra garcia p. Cytotherapy. 2024 Jan;26(1):25-35. doi: 10.1016/j.jcyt.2023.10.002. Epub 2023 Oct 29. Cytotherapy. 2024. PMID: 37897472 Clinical Trial.
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).
Pérez-Martínez A, Mora-Rillo M, Ferreras C, Guerra-García P, Pascual-Miguel B, Mestre-Durán C, Borobia AM, Carcas AJ, Queiruga-Parada J, García I, Sánchez-Zapardiel E, Gasior M, De Paz R, Marcos A, Vicario JL, Balas A, Moreno MA, Eguizabal C, Solano C, Arribas JR, Buckley RM, Montejano R, Soria B. Pérez-Martínez A, et al. EClinicalMedicine. 2021 Sep;39:101086. doi: 10.1016/j.eclinm.2021.101086. Epub 2021 Aug 13. EClinicalMedicine. 2021. PMID: 34405140 Free PMC article.
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.
García-García I, Guerra-García P, Ferreras C, Borobia AM, Carcas AJ, Queiruga-Parada J, Vicario JL, Mirones I, Solano C, Eguizabal C, Soria B, Pérez-Martínez A. García-García I, et al. Among authors: guerra garcia p. Trials. 2021 Oct 2;22(1):674. doi: 10.1186/s13063-021-05625-7. Trials. 2021. PMID: 34600562 Free PMC article.
CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation.
Martínez-Romera I, Galán-Gómez V, González-Martínez B, Guerra García P, San Román Pacheco S, Corral Sánchez D, Mozo Del Castillo Y, Bueno Sánchez D, Sisinni L, González Guerrero A, Castellano Dámaso S, Sánchez Zapardiel E, Ruz Caracuel B, Balas Pérez A, Pérez-Martínez A. Martínez-Romera I, et al. Among authors: guerra garcia p. Front Immunol. 2022 Aug 8;13:960412. doi: 10.3389/fimmu.2022.960412. eCollection 2022. Front Immunol. 2022. PMID: 36003375 Free PMC article.
Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.
García-García I, Dapía I, Montserrat J, Martinez de Soto L, Bueno D, Díaz L, Queiruga J, Rodriguez Mariblanca A, Guerra-García P, Ramirez E, Frías J, Pérez Martínez A, Carcas-Sansuan AJ, Borobia AM. García-García I, et al. Among authors: guerra garcia p. Front Pharmacol. 2021 Oct 20;12:717932. doi: 10.3389/fphar.2021.717932. eCollection 2021. Front Pharmacol. 2021. PMID: 34744712 Free PMC article.
Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine.
Galán-Gómez V, Matamala N, Ruz-Caracuel B, Valle-Simón P, Ochoa-Fernández B, Guerra-García P, Pernas-Sánchez A, Minguillón J, González B, Martínez-Romera I, San Román-Pacheco S, Estival-Monteliú P, Ibáñez-Navarro A, Pérez-Martínez A, Escudero-López A. Galán-Gómez V, et al. Among authors: guerra garcia p. J Pers Med. 2022 May 27;12(6):881. doi: 10.3390/jpm12060881. J Pers Med. 2022. PMID: 35743666 Free PMC article.
Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.
Bareke H, Ibáñez-Navarro A, Guerra-García P, González Pérez C, Rubio-Aparicio P, Plaza López de Sabando D, Sastre-Urgelles A, Ortiz-Cruz EJ, Pérez-Martínez A. Bareke H, et al. Among authors: guerra garcia p. Int J Mol Sci. 2023 May 5;24(9):8324. doi: 10.3390/ijms24098324. Int J Mol Sci. 2023. PMID: 37176035 Free PMC article. Review.
Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center.
Ochoa-Fernández B, Galán-Gómez V, Guerra-García P, Sanromán S, Martínez I, Bueno D, Mozo Y, Sisinni L, Losantos I, González B, Pérez-Martínez A. Ochoa-Fernández B, et al. Among authors: guerra garcia p. Front Pediatr. 2023 May 30;11:1166176. doi: 10.3389/fped.2023.1166176. eCollection 2023. Front Pediatr. 2023. PMID: 37325355 Free PMC article.
Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
Rubio-San-Simón A, Verdú-Amorós J, Hladun R, Juan-Ribelles A, Molero M, Guerra-García P, Pérez-Martínez A, Castañeda A, Cañete A, de Rojas T, Moreno L, Bautista F. Rubio-San-Simón A, et al. Clin Transl Oncol. 2021 Jan;23(1):183-189. doi: 10.1007/s12094-020-02399-3. Epub 2020 May 29. Clin Transl Oncol. 2021. PMID: 32472454 Free PMC article.
29 results